Plasmodium antibodies

US20220396614A1 · office US · priority 2019-07-01 · published 2022-12-15

… -years and therefore needs to be improved. A handful of studies have recently applied antibody-cloning strategies to isolate protective human antibodies against PfCSP and delineated their target epitopes as basis for the development of a second-generation PfCSP-based malaria vaccine (Triller et al.,

Inventor: Hedda WARDEMANN · Assignee: Deutsches Krebsforschungszentrum

Open the patent document · source query “malaria vaccine”